Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Galipeau

Showing results (71-80 of 193) with videos related to

Pageof 20
Sort By:
Cellular and Molecular Life Sciences : CMLS|April 17, 2026
Extracellular vesicles mediate intercellular transfer of PD-L1 and bystander T-cell suppressionAmar Yeware, Callum Brown, Chih-Chun Chang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell densityRaphaëlle Romieu-Mourez, Moïra François, Marie-Noëlle Boivin, et al.
Tissue Engineering. Part A|February 21, 2009
Design and fabrication of 3D porous scaffolds to facilitate cell-based gene therapyRouwayda El-Ayoubi, Nicoletta Eliopoulos, Robert Diraddo, et al.
Cancer Research|August 5, 2016
Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion ProteinSpencer Ng, Jiusheng Deng, Raghavan Chinnadurai, et al.
The Journal of Biological Chemistry|January 19, 2007
MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells: a molecular link between pro-MMP-2 activation, chemotaxis, and cell survivalJean-Christophe Currie, Simon Fortier, Asmaa Sina, et al.
Nature Medicine|July 10, 2013
MSCs: science and trialsDonald G Phinney, Jacques Galipeau, Mauro Krampera, et al.
Cytotherapy|October 7, 2023
Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific CommitteeKevin P Robb, Jacques Galipeau, Yufang Shi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2011
Novel TGF-beta antagonist inhibits tumor growth and angiogenesis by inducing IL-2 receptor-driven STAT1 activationClaudia Penafuerte, Norma Bautista-Lopez, Manaf Bouchentouf, et al.
Glycobiology|December 11, 2007
Tetra- and hexavalent mannosides inhibit the pro-apoptotic, antiproliferative and cell surface clustering effects of concanavalin-A: impact on MT1-MMP functions in marrow-derived mesenchymal stromal cellsSimon Fortier, Mohamed Touaibia, Simon Lord-Dufour, et al.
Cytotherapy|January 18, 2015
Human mesenchymal stromal cells suppress T-cell proliferation independent of heme oxygenase-1Seema R Patel, Ian B Copland, Marco A Garcia, et al.
Pageof 20

Showing results (71-80 of 193) with videos related to

Sort By:
Pageof 20
Cellular and Molecular Life Sciences : CMLS|April 17, 2026
Extracellular vesicles mediate intercellular transfer of PD-L1 and bystander T-cell suppressionAmar Yeware, Callum Brown, Chih-Chun Chang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell densityRaphaëlle Romieu-Mourez, Moïra François, Marie-Noëlle Boivin, et al.
Tissue Engineering. Part A|February 21, 2009
Design and fabrication of 3D porous scaffolds to facilitate cell-based gene therapyRouwayda El-Ayoubi, Nicoletta Eliopoulos, Robert Diraddo, et al.
Cancer Research|August 5, 2016
Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion ProteinSpencer Ng, Jiusheng Deng, Raghavan Chinnadurai, et al.
The Journal of Biological Chemistry|January 19, 2007
MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells: a molecular link between pro-MMP-2 activation, chemotaxis, and cell survivalJean-Christophe Currie, Simon Fortier, Asmaa Sina, et al.
Nature Medicine|July 10, 2013
MSCs: science and trialsDonald G Phinney, Jacques Galipeau, Mauro Krampera, et al.
Cytotherapy|October 7, 2023
Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific CommitteeKevin P Robb, Jacques Galipeau, Yufang Shi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2011
Novel TGF-beta antagonist inhibits tumor growth and angiogenesis by inducing IL-2 receptor-driven STAT1 activationClaudia Penafuerte, Norma Bautista-Lopez, Manaf Bouchentouf, et al.
Glycobiology|December 11, 2007
Tetra- and hexavalent mannosides inhibit the pro-apoptotic, antiproliferative and cell surface clustering effects of concanavalin-A: impact on MT1-MMP functions in marrow-derived mesenchymal stromal cellsSimon Fortier, Mohamed Touaibia, Simon Lord-Dufour, et al.
Cytotherapy|January 18, 2015
Human mesenchymal stromal cells suppress T-cell proliferation independent of heme oxygenase-1Seema R Patel, Ian B Copland, Marco A Garcia, et al.
Pageof 20